Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 100%Moderate 0 · 0%High 0 · 0%

Interferon vs glatiramer acetate

Withdrawals due to adverse events · patients with relapsing‐remitting multiple sclerosis

Interferons showed no clear difference in number of participants who dropped out for AEs Risk ratio (M‐H,… compared with glatiramer acetate (low certainty).

1 finding from 1 review

Interferons‐beta versus glatiramer acetate for relapsing‐remitting multiple sclerosis 2016 · Cochrane Headline outcomes only
RR 0.95 [0.64, 1.4]
4 studies · 2685 participants
Low